Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Novo Informatics was an India-based life sciences informatics and computational drug discovery company focused on in silico drug design and biological software for pharmaceutical, biotechnology, and academic customers. The company developed platform tools including Drugonov, which supported target selection through hit identification, and Proteonov, a protein structure annotation package. It appears to have operated primarily as a technology and services business rather than a therapeutics developer with a disclosed clinical pipeline. Publicly available business directory and private-company sources indicate the company was founded in 2011, had links to IIT Delhi's bioinformatics computing infrastructure, and was later marked out of business or struck off. Based on available evidence, Novo Informatics should be viewed as a defunct computational drug discovery/software company rather than an active biotech drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Novo Informatics.